Literature DB >> 24616345

Implementation of an electronic genomic and family health history tool in primary prenatal care.

Emily A Edelman, Bruce K Lin, Teresa Doksum, Brian Drohan, Vaughn Edelson, Siobhan M Dolan, Kevin S Hughes, James O'Leary, Shelley L Galvin, Nicole Degroat, Setul Pardanani, W Gregory Feero, Claire Adams, Renee Jones, Joan Scott.   

Abstract

"The Pregnancy and Health Profile," (PHP) is a free genetic risk assessment software tool for primary prenatal providers that collects patient-entered family (FHH), personal, and obstetrical health history, performs risk assessment, and presents the provider with clinical decision support during the prenatal encounter. The tool is freely available for download at www.hughesriskapps.net. We evaluated the implementation of PHP in four geographically diverse clinical sites. Retrospective chart reviews were conducted for patients seen prior to the study period and for patients who used the PHP to collect data on documentation of FHH, discussion of cystic fibrosis (CF) and hemoglobinopathy (HB) carrier screening, and CF and HB interventions (tests, referrals). Five hundred pre-implementation phase and 618 implementation phase charts were reviewed. Documentation of a 3-generation FHH or pedigree improved at three sites; patient race/ethnicity at three sites, father of the baby (FOB) race/ethnicity at all sites, and ancestry for the patient and FOB at three sites (P < 0.001-0001). CF counseling improved for implementation phase patients at one site (8% vs. 48%, P < 0.0001) and CF screening/referrals at two (2% vs. 14%, P < 0.0001; 6% vs. 14%; P = 0.05). Counseling and intervention rates did not increase for HB. This preliminary study suggests that the PHP can improve documentation of FHH, race, and ancestry, as well as the compliance with current CF counseling and intervention guidelines in some prenatal clinics. Future evaluation of the PHP should include testing in a larger number of clinical environments, assessment of additional performance measures, and evaluation of the system's overall clinical utility.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  clinical decision support; family health history; genetic screening; performance measure; prenatal care

Mesh:

Year:  2014        PMID: 24616345     DOI: 10.1002/ajmg.c.31389

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  6 in total

1.  Value of Genetics-informed Drug Dosing Guidance in Pregnant Women: A Needs Assessment with Obstetric Healthcare Providers at Johns Hopkins.

Authors:  Casey L Overby; Phillip Thompkins; Harold Lehmann; Christopher G Chute; Jeanne S Sheffield
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

2.  Survey of family history taking and genetic testing in pediatric practice.

Authors:  Robert A Saul; Tracy Trotter; Kerry Sease; Beth Tarini
Journal:  J Community Genet       Date:  2017-01-07

Review 3.  Review and Comparison of Electronic Patient-Facing Family Health History Tools.

Authors:  Brandon M Welch; Kevin Wiley; Lance Pflieger; Rosaline Achiangia; Karen Baker; Chanita Hughes-Halbert; Heath Morrison; Joshua Schiffman; Megan Doerr
Journal:  J Genet Couns       Date:  2018-03-06       Impact factor: 2.537

Review 4.  Implementing genomics and pharmacogenomics in the clinic: The National Human Genome Research Institute's genomic medicine portfolio.

Authors:  Teri A Manolio
Journal:  Atherosclerosis       Date:  2016-08-26       Impact factor: 5.162

Review 5.  Primary-care providers' perceived barriers to integration of genetics services: a systematic review of the literature.

Authors:  Natalie A Mikat-Stevens; Ingrid A Larson; Beth A Tarini
Journal:  Genet Med       Date:  2014-09-11       Impact factor: 8.822

6.  The design, implementation, and effectiveness of intervention strategies aimed at improving genetic referral practices: a systematic review of the literature.

Authors:  April Morrow; Priscilla Chan; Katherine M Tucker; Natalie Taylor
Journal:  Genet Med       Date:  2021-08-24       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.